Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emanuela Pesce

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
International Journal of Molecular Sciences|October 27, 2022
Virtual Drug Repositioning as a Tool to Identify Natural Small Molecules That Synergize with Lumacaftor in F508del-CFTR Binding and RescuingPaola Fossa, Matteo Uggeri, Alessandro Orro, et al.
Human Mutation|November 30, 2020
A high-content drug screening strategy to identify protein level modulators for genetic diseases: A proof-of-principle in autosomal dominant leukodystrophyElisa Giorgio, Emanuela Pesce, Elisa Pozzi, et al.
Cell Chemical Biology|May 15, 2018
Pharmacological Inhibition of the Ubiquitin Ligase RNF5 Rescues F508del-CFTR in Cystic Fibrosis Airway EpitheliaElvira Sondo, Federico Falchi, Emanuela Caci, et al.
Biochemical Pharmacology|July 11, 2025
Structure-guided combination of novel CFTR correctors to improve the function of F508del-CFTR in airway epithelial cellsDario Lunaccio, Caterina Allegretta, Emanuela Pesce, et al.
European Journal of Medicinal Chemistry|December 23, 2017
Synthesis and biological evaluation of novel thiazole- VX-809 hybrid derivatives as F508del correctors by QSAR-based filtering toolsNara Liessi, Elena Cichero, Emanuela Pesce, et al.
JCI Insight|February 9, 2018
Thymosin α-1 does not correct F508del-CFTR in cystic fibrosis airway epitheliaValeria Tomati, Emanuela Caci, Loretta Ferrera, et al.
International Journal of Molecular Sciences|July 1, 2020
GM1 as Adjuvant of Innovative Therapies for Cystic Fibrosis DiseaseGiulia Mancini, Nicoletta Loberto, Debora Olioso, et al.
Frontiers in Pharmacology|January 9, 2019
The Autophagy Inhibitor Spautin-1 Antagonizes Rescue of Mutant CFTR Through an Autophagy-Independent and USP13-Mediated MechanismEmanuela Pesce, Elvira Sondo, Loretta Ferrera, et al.
European Journal of Medicinal Chemistry|June 5, 2015
Synthesis and structure-activity relationship of aminoarylthiazole derivatives as correctors of the chloride transport defect in cystic fibrosisEmanuela Pesce, Marta Bellotti, Nara Liessi, et al.
Plos One|September 16, 2025
Alternative splicing and residual function potentially expand the therapeutic landscape of the CFTRdele2ins182 variantCristina Pastorino, Ludovica Menta, Emanuela Pesce, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
International Journal of Molecular Sciences|October 27, 2022
Virtual Drug Repositioning as a Tool to Identify Natural Small Molecules That Synergize with Lumacaftor in F508del-CFTR Binding and RescuingPaola Fossa, Matteo Uggeri, Alessandro Orro, et al.
Human Mutation|November 30, 2020
A high-content drug screening strategy to identify protein level modulators for genetic diseases: A proof-of-principle in autosomal dominant leukodystrophyElisa Giorgio, Emanuela Pesce, Elisa Pozzi, et al.
Cell Chemical Biology|May 15, 2018
Pharmacological Inhibition of the Ubiquitin Ligase RNF5 Rescues F508del-CFTR in Cystic Fibrosis Airway EpitheliaElvira Sondo, Federico Falchi, Emanuela Caci, et al.
Biochemical Pharmacology|July 11, 2025
Structure-guided combination of novel CFTR correctors to improve the function of F508del-CFTR in airway epithelial cellsDario Lunaccio, Caterina Allegretta, Emanuela Pesce, et al.
European Journal of Medicinal Chemistry|December 23, 2017
Synthesis and biological evaluation of novel thiazole- VX-809 hybrid derivatives as F508del correctors by QSAR-based filtering toolsNara Liessi, Elena Cichero, Emanuela Pesce, et al.
JCI Insight|February 9, 2018
Thymosin α-1 does not correct F508del-CFTR in cystic fibrosis airway epitheliaValeria Tomati, Emanuela Caci, Loretta Ferrera, et al.
International Journal of Molecular Sciences|July 1, 2020
GM1 as Adjuvant of Innovative Therapies for Cystic Fibrosis DiseaseGiulia Mancini, Nicoletta Loberto, Debora Olioso, et al.
Frontiers in Pharmacology|January 9, 2019
The Autophagy Inhibitor Spautin-1 Antagonizes Rescue of Mutant CFTR Through an Autophagy-Independent and USP13-Mediated MechanismEmanuela Pesce, Elvira Sondo, Loretta Ferrera, et al.
European Journal of Medicinal Chemistry|June 5, 2015
Synthesis and structure-activity relationship of aminoarylthiazole derivatives as correctors of the chloride transport defect in cystic fibrosisEmanuela Pesce, Marta Bellotti, Nara Liessi, et al.
Plos One|September 16, 2025
Alternative splicing and residual function potentially expand the therapeutic landscape of the CFTRdele2ins182 variantCristina Pastorino, Ludovica Menta, Emanuela Pesce, et al.
Pageof 5